National Eye Institute; Notice of Open Meeting, 27821 [07-2425]

Download as PDF Federal Register / Vol. 72, No. 95 / Thursday, May 17, 2007 / Notices 3. Conduct clinical trials of recombinant vaccines alone and in combination therapies, and 4. Provide Drug Master Files currently supporting the clinical use of the recombinant poxvirus vaccines. If interested in the above described CRADA, please submit a statement of interest and capability to Kevin Chang, PhD, in the NCI Technology Transfer Center at changke@mail.nih.gov or 301– 496–0477. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Bethesda Marriott, 5151 Pooks Hill Road, Bethesda, MD 20814. Contact Person: Martina Schmidt, Ph.D, Scientific Review Administrator, Office of Scientific Review, National Center for Complementary, and Alternative Medicine, NIH, 6707 Democracy Blvd., Suite 401, Bethesda, MD 20892, (301) 594–3456. schmidma@mail.nih.gov. Dated: May 11, 2007. Steven M. Ferguson, Director, Division of Technology Development and Transfer, Office of Technology Transfer, National Institutes of Health. [FR Doc. E7–9541 Filed 5–16–07; 8:45 am] Dated: May 8, 2007. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. 07–2427 Filed 5–16–07; 8:45 am] BILLING CODE 4140–01–M BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institutes of Health National Center for Complementary and Alternative Medicine; Notice of Closed Meeting National Eye Institute; Notice of Open Meeting pwalker on PROD1PC71 with NOTICES Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Center for Complementary and Alternative Medicine Special Emphasis Panel; Basic Science. Date: June 11–12, 2007. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Courtyard Marriott, Washingtonian Center, 240 Boardwalk Place (Rio), Gaithersburg, MD 20878. Contact Person: Dale L. Birkle, Ph.D, Scientific Review Administrator, Office of Scientific Review, National Center for Complementary, and Alternative Medicine, NIH, 6707 Democracy Blvd., Suite 401, Bethesda, MD 20892, (301) 451–6570. birkled@mail.nih.gov. Name of Committee: National Center for Complementary and Alternative Medicine Special Emphasis Panel; Centers of Excellence for Research on Complementary and Alternative Medicine. Date: June 20–22, 2007. VerDate Aug<31>2005 17:15 May 16, 2007 Jkt 211001 The National Eye Institute will host an Ocular Epidemiology Program Planning Panel Meeting to discuss research needs and opportunities in ocular epidemiology. The meeting will be open to the public. The thoughts and input from this meeting will be given by the panel members individually and incorporated into a report that will be given to the National Eye Institute. Name of Panel: Ocular Epidemiology Panel. Date: May 24–25, 2007. Time: 8 a.m.–5 p.m. Agenda: To discuss the Ocular Epidemiology Research. Place: Hyatt Regency Bethesda, One Bethesda Metro Center, (7400 Wisconsin Avenue), Bethesda, MD 20814. Contact Person: Mr. Michael Davis, Associate Director for Science Policy and Legislation, National Eye Institute, Bldg. 31; Room 6A25, 31 Center Drive MSC 2510, Bethesda, MD 20892, (301) 496–4308. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. Any interested person may file written comments with the panel by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. (Catalogue of Federal Domestic Assistance Program Nos. 93.867, Vision Research, National Institutes of Health, HHS) PO 00000 Frm 00022 Fmt 4703 Sfmt 4703 27821 Dated: May 8, 2007. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. 07–2425 Filed 5–16–07; 8:45 am] BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Eye Institute; Notice of Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of the National Advisory Eye Council. The meeting will be open to the public as indicated below, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Advisory Eye Council. Date: June 7, 2007. Closed: 8:30 a.m. to 10:30 a.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Natcher Building, 45 Center Drive, Conference Room D, Bethesda, MD 20892. Open: 10:30 a.m. to Adjournment. Agenda: Following opening remarks by the Director, NEI there will be presentations by the staff of the Institute and discussions concerning Institute programs. Place: National Institutes of Health, Natcher Building, 45 Center Drive, Conference Room D, Bethesda, MD 20892. Contact Person: Lore Anne McNicol, PhD, Director, Division of Extramural Research, National Eye Institute, National Institutes of Health, Bethesda, MD 20892, (301) 451–2020. Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. E:\FR\FM\17MYN1.SGM 17MYN1

Agencies

[Federal Register Volume 72, Number 95 (Thursday, May 17, 2007)]
[Notices]
[Page 27821]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 07-2425]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Eye Institute; Notice of Open Meeting

    The National Eye Institute will host an Ocular Epidemiology Program 
Planning Panel Meeting to discuss research needs and opportunities in 
ocular epidemiology. The meeting will be open to the public.
    The thoughts and input from this meeting will be given by the panel 
members individually and incorporated into a report that will be given 
to the National Eye Institute.

    Name of Panel: Ocular Epidemiology Panel.
    Date: May 24-25, 2007.
    Time: 8 a.m.-5 p.m.
    Agenda: To discuss the Ocular Epidemiology Research.
    Place: Hyatt Regency Bethesda, One Bethesda Metro Center, (7400 
Wisconsin Avenue), Bethesda, MD 20814.
    Contact Person: Mr. Michael Davis, Associate Director for 
Science Policy and Legislation, National Eye Institute, Bldg. 31; 
Room 6A25, 31 Center Drive MSC 2510, Bethesda, MD 20892, (301) 496-
4308.
    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.
    Any interested person may file written comments with the panel 
by forwarding the statement to the Contact Person listed on this 
notice. The statement should include the name, address, telephone 
number and when applicable, the business or professional affiliation 
of the interested person.

(Catalogue of Federal Domestic Assistance Program Nos. 93.867, 
Vision Research, National Institutes of Health, HHS)

    Dated: May 8, 2007.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 07-2425 Filed 5-16-07; 8:45 am]
BILLING CODE 4140-01-M

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.